Delayed surgical step-up approach best for treating necrotizing pancreatitis: Study
China: A delayed surgical step-up approach (DSU) is the optimal strategy for treating necrotizing pancreatitis, says a recent study.
The findings from a meta-analysis of randomized controlled trials (RCTs) were published in the World Journal of Emergency Surgery on January 27 2023. In clinical practice, the researchers suggest avoiding drainage alone.
The study further found that any interventions should be postponed for at least four weeks. The findings might help clinicians choose the optimal treatment strategy in clinical practice.
Acute pancreatitis (AP) is a pancreas' inflammatory disorder with 10% to 40% mortality. Two significant forms of acute pancreatitis exist: necrotizing and interstitial. About 20% of acute pancreatitis patients advance to necrotizing pancreatitis (NP), which is linked with walled-off necrosis (WON) or acute necrotic collections (ANC), with a significant mortality risk of 20–30%. Intervention is required in 40–63% of patients who develop necrotizing pancreatitis.
A series of randomized controlled trials have examined the safety and efficacy of different things and methods of interventions. However, there still needs to be a consensus on the optimal treatment strategy. Considering this, Yang Yang, Tianjin Medical University, Tianjin, China, and colleagues conducted a comprehensive Bayesian network meta-analysis (NMA) of RCTs to determine the optimal intervention and timing for necrotizing pancreatitis comparing safety and efficacy through direct and indirect evidence.
For this purpose, the researchers searched the online databases until November 30, 2022. A systematic review and Bayesian NMA were performed following the PRISMA guidelines. Trials that compared different treatment strategies for NP were included.
The authors analyzed ten studies comprising 570 patients and eight treatment strategies.
The study led to the following findings:
- The researchers identified no statistically significant differences comparing odds ratios, but the surface confirmed the trends under the cumulative ranking (SUCRA) scores.
- The interventions having a low rate of mortality included delayed surgical step-up approach (DSU), delayed surgery (DS), and delayed endoscopic step-up approach (DEU). In contrast, the interventions with a low rate of significant complications were DEU, DSU and DS.
- According to the clustered ranking plot, DSU was overall superior in lowering mortality and major complications, while delayed drainage performed the worst.
- Analysis of the secondary endpoints confirmed DEU and DSU's superiority concerning individual components of major complications (pancreatic fistula, organ failure, bleeding, and visceral organ or enterocutaneous fistula), endocrine insufficiency, exocrine insufficiency, and length of stay. Overall, DSU was superior to other interventions.
"The network meta-analysis on comparing the outcomes of 8 interventions for NP across ten studies with a total of 816 patients identified the optimal treatment strategy for NP with low risk of major complications and mortality as DSU," the researchers wrote.
"Our findings indicated that postponement strategy interventions and step-up approach, usually selected in the current clinical practice, were reasonable," they conclude.
Reference:
Yang, Y., Zhang, Y., Wen, S. et al. The optimal timing and intervention to reduce mortality for necrotizing pancreatitis: a systematic review and network meta-analysis. World J Emerg Surg 18, 9 (2023). https://doi.org/10.1186/s13017-023-00479-7
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.